cas 1213334-10-1|| where to buy (S)-2-(3,5-Dimethylphenyl)pyrrolidine

Nom du produit:(S)-2-(3,5-Dimethylphenyl)pyrrolidine

IUPAC Name:(2S)-2-(3,5-dimethylphenyl)pyrrolidine

Unité d'emballage	Stock disponible	Prix($)
CM198317-250mg	in stock	Ůǎ
CM198317-1g	in stock	ĳħŌ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1213334-10-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1213334-10-1; Formule moléculaire:C12H17N; Point de fusion:-; Code SMILES:CC1=CC(C)=CC([C@H]2NCCC2)=C1; Densité:

: Numéro de catalogue:CM198317; Poids moléculaire:175.28; Point d'ébullition:; N° Mdl:MFCD07772459; Stockage:Keep in dark place, store at 2-8°C.

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

: Aticaprant; Major depressive disorder is a leading cause of disability worldwide. Kappa opioid receptors (KORs) are a promising new therapeutic target for major depressive disorder and anhedonia. Aticaprant is a KOR antagonist developed by Johnson & Johnson’s Janssen. Aticaprant is currently being tested as an adjunctive therapy to a current antidepressant in MDD patients with a focus on treating anhedonia. Studies are expected to be completed in mid-to-late 2024 and 2025.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.